UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 7, 2007
BIOMET, INC.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
| Indiana | 0-12515 | 35-1418342 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
56 East Bell Drive
Warsaw, Indiana 46582
(Address of Principal Executive Offices, Including Zip Code)
(574) 267-6639
(Registrant’s Telephone Number, Including Area Code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| x | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 8.01 | Other Events. |
On June 7, 2007, Biomet, Inc. (“Biomet”) announced that it cancelled the special meeting of shareholders previously scheduled for Friday, June 8, 2007 to consider and vote on the Agreement and Plan of Merger dated December 18, 2006, by and between Biomet and a consortium of private equity funds. The special meeting has been cancelled as a result of the adoption by Biomet’s board of directors on June 6, 2007 of an amended and restated Agreement and Plan of Merger between the same parties. For additional information about the amended and restated Agreement and Plan of Merger and the tender offer contemplated thereunder, refer to the Current Report on Form 8-K expected to be filed later today by Biomet with the SEC.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| BIOMET, INC. | ||
| /s/ Bradley J. Tandy | ||
| By: | Bradley J. Tandy | |
| Its: | Senior Vice President, General Counsel and Secretary | |
Date: June 7, 2007
3